A core fee of €15 is to be maintained for all quadrivalent influenza vaccinations administered by GPs in the 2021/22 influenza season, the Primary Care Reimbursement Service (PCRS) has confirmed.
The fee is to be paid for adjuvanted quadrivalent influenza vaccines and quadrivalent influenza vaccines to patients in the recommended HSE patient groups, both GMS and non-GMS.
In addition to this, each GP is eligible for a further payment of €100 for every 10 unique patients to whom he/she administers one of the quadrivalent influenza vaccines.
A fee of €20 is to apply for vaccinations administered using the (nasal) live attenuated influenza vaccine for children aged from two to 17 years inclusive.
A further payment of €150 is to be paid for every 10 unique patients, aged from two to 17 years, administered the (nasal) live attenuated influenza vaccine.
Payment of €28.50 is to continue for administration of a pneumococcal polysaccharide vaccine (PPV) to an eligible individual in the relevant at-risk group under the GMS. Payment is made provided that the vaccine is not administered by the GP, or by another GP in the same practice, on the same day as an influenza vaccine.
The existing fee of €42.75 is to continue to apply for the administration of combined influenza and pneumococcal polysaccharide vaccine on the same day by the GP, or another GP in the same practice.
The seasonal influenza vaccination programme for winter 2021/22 began on the week of 4 October.